What is the price-to-earnings ratio of Faes Farma?
The price-earnings ratio of Faes Farma is currently 2.43.
Faes Farma P/S 2024
Faes Farma P/S
2.43
Ticker
FAE.MC
ISIN
ES0134950F36
WKN
A0MKAC
As of Nov 25, 2024, Faes Farma's P/S ratio stood at 2.43, a 7.05% change from the 2.27 P/S ratio recorded in the previous year.
The Faes Farma P/S history
Faes Farma Aktienanalyse
What does Faes Farma do?
The history of Faes Farma SA dates back to 1933, when the company was founded in Barcelona, Spain. The founders had a vision to develop innovative products that would contribute to improving the health and well-being of people. Over the following decades, the company grew continuously and established itself as one of the leading players in the pharmaceutical industry. The business model of Faes Farma SA is focused on the development and marketing of products for the healthcare industry. The company relies on research and development to develop innovative solutions for various therapeutic areas. Faes Farma SA distributes its products worldwide through a network of partners and distributors, with a focus on Europe and Latin America. Faes Farma SA operates in three different divisions. The first division is pharmaceuticals, where the company offers products for various areas such as respiratory diseases, allergies, pain, and inflammation. An important part of this segment is the product Bilastine, which is used for the treatment of allergies and is considered an alternative to antihistamines. The second division is animal health. Here, Faes Farma SA offers products for the treatment of pets, including preparations against fleas, ticks, and worms. One of the most well-known products in this area is the Stangest brand, which is considered the leading brand for animal health in Spain. The third division of Faes Farma SA is the business of medical devices and diagnostics. Here, the company offers a wide range of products for various medical applications, including devices for monitoring vital signs and diagnostics for infectious diseases. Overall, Faes Farma SA is a company with a diversified product portfolio that is of interest to both end consumers and healthcare professionals and pet owners. The company has continuously developed and invested in research and development in recent years to expand its product offering and provide innovative solutions for various medical needs. Faes Farma SA is a company that stands out for its commitment to the development of innovative products and its dedication to the health and well-being of humans and animals. With a strong focus on research and development and a wide distribution network, the company has solidified its position in the pharmaceutical industry and will continue to play an important role in the market. Faes Farma ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Faes Farma's P/S Ratio
Faes Farma's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Faes Farma's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Faes Farma's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Faes Farma’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Faes Farma stock
How has the price-earnings ratio of Faes Farma changed compared to last year?
The price-to-earnings ratio of Faes Farma has increased by 7.05% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Faes Farma high compared to other companies?
Yes, the price-to-earnings ratio of Faes Farma is high compared to other companies.
How does an increase in the price-earnings ratio of Faes Farma affect the company?
An increase in the price-earnings ratio of Faes Farma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Faes Farma affect the company?
A decrease in the price-earnings ratio of Faes Farma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Faes Farma?
Some factors that influence the price-earnings ratio of Faes Farma are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Faes Farma pay?
Over the past 12 months, Faes Farma paid a dividend of 0.16 EUR . This corresponds to a dividend yield of about 4.48 %. For the coming 12 months, Faes Farma is expected to pay a dividend of 0.17 EUR.
What is the dividend yield of Faes Farma?
The current dividend yield of Faes Farma is 4.48 %.
When does Faes Farma pay dividends?
Faes Farma pays a quarterly dividend. This is distributed in the months of February, May, February, August.
How secure is the dividend of Faes Farma?
Faes Farma paid dividends every year for the past 24 years.
What is the dividend of Faes Farma?
For the upcoming 12 months, dividends amounting to 0.17 EUR are expected. This corresponds to a dividend yield of 4.88 %.
In which sector is Faes Farma located?
Faes Farma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Faes Farma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Faes Farma from 7/8/2024 amounting to 0.116 EUR, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.
When did Faes Farma pay the last dividend?
The last dividend was paid out on 7/8/2024.
What was the dividend of Faes Farma in the year 2023?
In the year 2023, Faes Farma distributed 0.035 EUR as dividends.
In which currency does Faes Farma pay out the dividend?
The dividends of Faes Farma are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Faes Farma
Our stock analysis for Faes Farma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Faes Farma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
